Stocks
Danaher CorporationDHR
NYSEHealthcareLife Sciences Tools & Services$187.32+0.57%
A diversified life sciences and diagnostics company, it develops and manufactures instruments, consumables, and services used in bioprocessing, clinical diagnostics, and environmental applications. The company has expanded through acquisitions and portfolio optimization, sharpening its focus on higher-margin life sciences and laboratory tools. Investors track its exposure to biopharma research funding, hospital spending, and recurring revenue from consumables and service contracts.
Market Cap: $132.5B52W Range: $171.00 – $242.80
Congressional Interest in Danaher Corporation (DHR)
19 members of Congress have disclosed 50 trades in Danaher Corporation (DHR), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
19
Buys
24
Sells
26
Who in Congress Is Trading DHR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-03-26 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2018-03-09 | John F Reed | sell | $1K – $15K |